Key result
The provided text contains only the journal's editorial board information and does not include the study data.
Why the study?
Do polymorphisms in COX-1 and GP VI genes associate with aspirin non-response in patients with stable coronary artery disease?
Population
101 patients with stable coronary artery disease (CAD) treated with aspirin (mean 100 mg/d)
Comparison
Evaluation of genetic polymorphisms in COX-1 and… vs Aspirin responders vs. non-responders
Design
Cross-sectional
Authors
Loading...
Different assays identify genetically distinct aspirin non-responders; hypothesis-generating for genotyping in stable CAD.
Do polymorphisms in COX-1 and GP VI genes associate with aspirin non-response in patients with stable coronary artery disease?
Different methods of evaluating aspirin efficacy identify different non-responders, who exhibit distinct genotypic profiles in COX-1 and GP VI genes.
Mikkelsson et al. (2006) studied coronary artery disease. aspirin was evaluated. The provided text contains only the journal's editorial board information and does not include the study data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: